A carregar...
IPX066: a new intermediate-and extended-release carbidopa–levodopa formulation
Carbidopa–levodopa (CD–LD) is the mainstay of treatment for Parkinson’s disease (PD), yet most patients with advanced PD develop motor fluctuations with time when treated with CD–LD. Development of longer-acting CD–LD formulations is a major goal for reducing motor fluctuations in advanced PD. IPX06...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3910659/ https://ncbi.nlm.nih.gov/pubmed/24501594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.13.4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|